These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7856285)

  • 1. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E
    Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of ACE-inhibition in the therapy of chronic heart insufficiency].
    Drexler H; Just H
    Wien Med Wochenschr; 1990 Jan; 140(1-2):40-5. PubMed ID: 2137955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rational therapy of heart failure].
    Werner MG; Schmieder RE
    Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classic treatment of chronic heart insufficiency. What if new?].
    Aumont MC; Agnola D; Juliard JM; Karrillon G
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):599-602. PubMed ID: 7487308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitors in congestive heart failure.
    Kantner TR
    J Fam Pract; 1992 Sep; 35(3):305-14. PubMed ID: 1517728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
    Halawa B
    Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of heart failure with ACE inhibitors--"evidence-based medicine" and clinical reality].
    Auer J; Berent R; Kirchgatterer A; Weber T; Mayr H; Maurer E; Eber B
    Wien Med Wochenschr; 1999; 149(21-22):587-92. PubMed ID: 10666823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of ACE inhibitors in heart failure (clinical aspects)].
    Riegger AJ
    Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.